DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹139 Cr | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr | ₹-24 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹139 Cr |
Mar2023 | ₹-936 Cr |
Mar2022 | ₹-70 Cr |
Mar2021 | ₹1,275 Cr |
Mar2020 | ₹-24 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹139 Cr | Positive | |
Mar2023 | ₹-936 Cr | Negative | |
Mar2022 | ₹-70 Cr | Negative | |
Mar2021 | ₹1,275 Cr | Positive | |
Mar2020 | ₹-24 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹112,699.2 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,824.0 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,151.0 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 4.7% |
11.9% |
14.5% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses